Parenteral Drug Association
Connecting People, Science and Regulation ®
Jennifer Loughman and Paul Lopolito, STERIS
Brian Hawkins, PhD, Pluristyx, Inc.
Cristiana Campa, GSK, and Michael De Felippis, Eli Lilly and Company
Stephan Krause, PhD, AstraZeneca Biologics, and Jens Schletter, PhD, Novartis
Barbara Rellahan, Amgen
Martijn van der Plas, PhD, Medicines Evaluation Board, and Michael De Felippis, PhD, Eli Lilly
Austin Caudle, IQVIA
Rebecca Stauffer, PDA
Emanuela Lacana, PhD, U.S. FDA
Joshua Eaton, PDA
Pieter-Jan Van Bockstal, Ghent University, Jos Corver, RheaVita, and Thomas De Beer, Ghent University
Austin Caudle, Metabolon, Inc.
Andy Fry, Team Consulting
Thomas R. Kreil, PhD, Global Pathogen Safety, Shire
